ASTH (Astrana Health) Retained Earnings: $323 Mil (As of Mar. 2026)


ASTH Astrana Health Inc ASTH
87 GF Score
Price $45.02
GF Value $82.34
Valuation Significantly Undervalued
! 8 Warning Signs
View Full Analysis

What is Astrana Health Retained Earnings?

Astrana Health ASTH +1.35% 87 Retained Earnings is $323 Mil as of Mar. 2026. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.34 (Significantly Undervalued). The stock has 8 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Astrana Health's retained earnings for the quarter that ended in Mar. 2026 was $323 Mil.

Astrana Health's quarterly retained earnings increased from Sep. 2025 ($302 Mil) to Dec. 2025 ($308 Mil) and increased from Dec. 2025 ($308 Mil) to Mar. 2026 ($323 Mil).

Astrana Health's annual retained earnings increased from Dec. 2023 ($243 Mil) to Dec. 2024 ($286 Mil) and increased from Dec. 2024 ($286 Mil) to Dec. 2025 ($308 Mil).


Astrana Health  (NAS:ASTH) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Astrana Health Retained Earnings Historical Data

* Premium members only.

The historical data trend for Astrana Health's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astrana Health Retained Earnings Chart

Astrana Health Annual Data
Trend Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 137.25 182.42 243.13 286.28 308.38

Astrana Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 292.88 302.21 302.49 308.38 322.71
ASTH
87GF Score
Astrana Health Inc ASTH
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astrana Health Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $323 Mil mean?
Astrana Health (ASTH) has a Retained Earnings of $323 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Astrana Health and its competitors.
Is Astrana Health's Retained Earnings too high?
Astrana Health's current Retained Earnings is $323 Mil. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Retained Earnings compare to SGRY and SEM?
Astrana Health's Retained Earnings of $323 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Healthcare Providers & Services company?
A good Retained Earnings depends on the Healthcare Providers & Services industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Astrana Health and its competitors. Astrana Health's current Retained Earnings is $323 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.34, compared to a current price of $45.02 — trading 45.3% below its estimated fair value. The current Retained Earnings is $323 Mil. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Astrana Health (ASTH), the current Retained Earnings is $323 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astrana Health (ASTH) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of $45.02 is trading 45.3% below its estimated GF Value™ of $82.34. GuruFocus considers Astrana Health to be Significantly Undervalued.

Key valuation signals for ASTH:

  • Retained Earnings: $323 Mil
  • GF Value™: $82.34 vs. price of $45.02 (45.3% below fair value)
  • GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Astrana Health Business Description

Other Exchanges 3AM:Germany
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score

Get the complete analysis for ASTH

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$45.02
Price
$82.34
GF Value